India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
The European Commission’s green light marks Breyanzi’s fourth indication in Europe and extends access to patients across all EU and EEA countries
Data show adjuvant Verzenio plus endocrine therapy extends overall survival and sustains long-term improvements in invasive disease-free survival
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
Jaypirca is making waves in the fight against B-cell malignancies
Subscribe To Our Newsletter & Stay Updated
